Global Virology and Bacteriology Market Competition, Forecast & Opportunities, 2020-2025 - Molecular Diagnostics, Immunoassays, Diagnostic Imaging, Information Technology -

·4-min read

The "Global Virology and Bacteriology Market, by Technology (Molecular Diagnostics, Immunoassays, Diagnostic Imaging, Information Technology), by Disease, by End User, by Region, Competition, Forecast & Opportunities, 2025" report has been added to's offering.

The Global Virology and Bacteriology Market is expected to grow at a CAGR of around 12% during 2021 - 2025.

The Global Virology and Bacteriology Market is driven by rising population getting affected by viral and bacterial infections. Moreover, governments across the globe are investing more on healthcare infrastructure, which is positively impacting the market growth. Also, continuous technological innovations in research and development activities is further expected to bolster the growth of the market over the next few years.

The Global Virology and Bacteriology Market is segmented based on technology, disease, end-user, company, and region. Based on technology, the market can be categorized into molecular diagnostics, immunoassays, diagnostic imaging, and information technology.

Out of these, the molecular diagnostics segment dominated the market in 2019 and is expected to maintain its leading position during the forecast period as well. This can be ascribed to the fact that this technology allows the detection of lower amount of infectious agents, thereby detecting the infection at an early stage than was previously possible.

Major players operating in the Global Virology and Bacteriology Market include Fujirebio Diagnostics Inc., Cepheid, Diasorin, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Scienion AG, Grifols, Qiagen, Eiken Chemical Co Ltd, Sequenom, bioMerieux SA, Siemens AG, Hologic Inc., Diamedix Inc., Leica Biosystems Nussloch GmbH, F. Hoffmann-La Roche Ltd, Abbott, GSK Biologicals, Roche, Affymetrix, among others.

The companies are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers, acquisitions, collaborations and partnerships.

Years considered for this report:

  • Historical Years: 2015 - 2018

  • Base Year: 2019

  • Estimated Year: 2020

  • Forecast Period: 2021 - 2025

Key Topics Covered:

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Virology and Bacteriology Market

4. Executive Summary

5. Voice of Customer

6. Global Virology and Bacteriology Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Technology (Molecular Diagnostics, Immunoassays, Diagnostic Imaging, Information Technology)

6.2.2. By Disease (Respiratory System, Urinary Tract, And Bloodstream Diseases; Gastrointestinal and Periodontal Diseases; Sexually Transmitted Diseases)

6.2.3. By End User (Clinics, Hospitals, Diagnostic Centers, Research Laboratories, And Blood Banks)

6.2.4. By Company (2019)

6.2.5. By Region

6.3. Market Attractiveness Index

7. Asia-Pacific Virology and Bacteriology Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Technology

7.2.2. By Disease

7.2.3. By End User

7.2.4. By Country

7.3. Asia-Pacific: Country Analysis

8. Europe Virology and Bacteriology Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Technology

8.2.2. By Disease

8.2.3. By End User

8.2.4. By Country

8.3. Europe: Country Analysis

9. North America Virology and Bacteriology Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Technology

9.2.2. By Disease

9.2.3. By End User

9.2.4. By Country

9.3. North America: Country Analysis

10. South America Virology and Bacteriology Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Technology

10.2.2. By Disease

10.2.3. By End User

10.2.4. By Country

10.3. South America: Country Analysis

11. Middle East and Africa Virology and Bacteriology Market Outlook

11.1. Market Size & Forecast

11.1.1. By Value

11.2. Market Share & Forecast

11.2.1. By Technology

11.2.2. By Disease

11.2.3. By End User

11.2.4. By Country

11.3. MEA: Country Analysis

12. Market Dynamics

12.1. Drivers

12.2. Challenges

13. Market Trends & Developments

14. Patent Analysis

15. Competitive Landscape

15.1. Fujirebio Diagnostics Inc.

15.2. Cepheid Inc.

15.3. DiaSorin S.p.A.

15.4. Bio-Rad Laboratories Inc.

15.5. Thermo Fisher Scientific Inc.

15.6. Scienion AG

15.7. Grifols S.A.

15.8. Qiagen N.V.

15.9. Eiken Chemical Co. Ltd.

15.10. Sequenom Inc.

15.11. bioMerieux SA

15.12. Siemens AG

15.13. Hologic Inc.

15.14. Diamedix Corporation

15.15. Leica Biosystems Nussloch GmbH

15.16. F. Hoffmann-La Roche AG

15.17. Abbott Laboratories

15.18. GSK Biologicals SA

16. Strategic Recommendations

For more information about this report visit

View source version on

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900